Epocrates' Prescription for Medical App Overload is Here

San Mateo, Calif., October 27, 2011

Epocrates' Prescription for Medical App Overload is Here
#1 Mobile Drug Reference Becomes Platform for Quick Access and Discovery of Relevant Medical Apps

SAN MATEO, Calif., October 27, 2011 - With thousands of medical apps now available, clinicians are feeling overwhelmed, with more than 85 percent reportedly downloading apps they do not use. Epocrates, Inc. (NASDAQ: EPOC), developers of the most used medical app, has introduced a solution to app overload. Its industry leading Epocrates Rx reference has been reimagined, creating a customizable user experience and a platform that provides clinicians with faster access to trusted drug content and serves as a way to surface rich medical content.

"Epocrates has made my single most used app even more useful, which I didn't even know was possible," said Dr. Jake Varghese, family practitioner. "The design is simply elegant; I can get in and out of the app so quickly that it allows me to maintain focused on my patient. Plus, it reveals additional apps that I'm actually interested in and likely may have not found otherwise."

Research shows that more than 75 percent of clinicians prefer to download apps from a company they know. As a top mobile developer in the medical community, Epocrates has created a platform that allows healthcare professionals to conveniently add, customize and prioritize medical apps and content most relevant to their practice. This also allows helpful tools and manufacturer resources to be more prominently displayed and accessible, which, for example, enable users to request drug samples or directly report an adverse drug event.

"Mobile apps are only as valuable as they are useful," said Rose Crane, president and chief executive officer of Epocrates. "We've advanced the user experience of our world-class drug reference app and added a singular channel to discover, store and access reliable tools. Furthermore, this is a fresh foundation for new partner engagements and opportunities to deliver even more value-add resources to our network."

With the Epocrates drug reference as the foundation, the company has built in an app directory that provides healthcare professionals with convenient, centralized access to a portfolio of high-value reference, education and clinical apps. The Epocrates App Directory features a vetted selection of apps such as Netter's Anatomy Flash Cards, Growth Evaluation Tool, BMI Tool, Pregnancy and Infant Care MRC and Epocrates CME. Clinicians will also receive recommendations for additional apps based on designated areas of interest.

The in-app directory and new user experience for the Epocrates Rx product line is now available on Apple devices (iPhone, iPod touch and iPad) and may be downloaded from the Apple App Store.

About Epocrates, Inc.
Epocrates, Inc. (NASDAQ: EPOC), developers of the #1 most used mobile medical app among U.S. physicians, creates point-of-care digital solutions that enhance the practice of medicine. More than 1.4 million healthcare professionals, including 50 percent of U.S. physicians, use Epocrates' solutions to help improve patient care and practice efficiencies with its drug reference, educational and clinical apps. The new Epocrates mobile and web-based EHR solution, designed for solo and small group practice physicians, is affordable, easy-to-use and further supports physician workflow and patient outcomes. The company also partners with the healthcare industry, including top pharmaceutical companies, to engage with its clinician network through effective, interactive services. For more information about Epocrates, please visit www.epocrates.com/company.

Epocrates and Epocrates Rx are trademarks of Epocrates, Inc., in the U.S. and other countries.


Erica Sniad Morgenstern
Director, Public Relations and Communication
(650) 227-6907

Media Contact

Holly Spring
athenahealth, Inc. (Media)

Dana Quattrochi
athenahealth, Inc. (Investors)

April Marks
Epocrates, Inc. (Media)